The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...

From the late 1800's, through the early part of the last century, people on the west side of the Bitterroot Valley lived in ...

The UK Health Security Agency identified four virus families—some deadlier than COVID-19—with high pandemic potential. One, ...

Promega technology used in the development of vaccines for infectious viral diseases will support a collaboration between Charles River and the Coalition for Epidemic Preparedness Innovations' (CEPI's ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Marburg virus belongs to the genus Marburgvirus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates.

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful.